Gender peculiarities of clinical manifestations in patients with arterial hypertension and chronic heart failure in combination with senile asthenia syndrome


DOI: https://dx.doi.org/10.18565/therapy.2024.1.40-52

Safronenko V.A., Chesnikova A.I.

Rostov State Medical University of the Ministry of Healthcare of Russia, Rostov-on-Don
Abstract. Prevalence of comorbid pathology naturally increases with age in both men and women, with the percentage of arterial hypertension (AH) and chronic heart failure (CHF) especially increasing.
The aim: to identify gender characteristics of risk factors (RF), comorbidities, clinical symptoms and cognitive functions in elderly patients with AH and CHF depending on the presence of senile asthenia syndrome (SAS).
Material and methods. The study included 161 patients with AH and CHF aged 80 years and older. Taking into account the presence of SAS, patients were divided into 2 groups: 1st – persons with hypertension, CHF and SAS (n = 84), 2nd – persons with hypertension, CHF without SAS (n = 77). All participants were assessed for risk factors and concomitant pathologies, they underwent physical examination, laboratory and instrumental studies, and testing according to the MMSE scale.
Results. In “fragile” female patients, in comparison with “fragile” male patients and “strong” females, statistically significantly more severe asthenia was observed, atrial fibrillation, chronic kidney disease, anemia, higher systolic and lower diastolic blood pressure indexes, more a high score on the RSCS scale, lower exercise tolerance, and also dementia of mild degree of severity. “Strong” females more often had an obesity comparatively to “strong” male and “fragile” female patients.
Conclusion. The results of the study allow us to make a conclusion, on the one hand, about the influence of SAS at clinical manifestations in patients with AH and CHF, and on the other, about the gender peculiarities of clinical manifestations in patients with AH and CHF, depending on the SAS presence.

Literature


1. Дадашова Г.M. Гендерные особенности хронической сердечной недостаточности. Клиническая медицина. 2015; 93(1): 71–75. (Dadashova G.M. Gender features of chronic heart failure. Klinicheskaya meditsina = Clinical Medicine. 2015; 93(1): 71–75 (In Russ.)). EDN: TIKBCJ.


2. Jessup M., Abraham W.T., Casey D.E. et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. JACC. 2009; 53(15): 1343–82. https://doi.org/10.1016/j.jacc.2008.11.009. PMID: 19324967.


3. Терещенко С.Н., Галявич А.С., Ускач Т.М. с соавт. Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(11): 311–374. (Tereshchenko S.N., Galyavich A.S., Uskach T.M. et al. 2020 clinical practice guidelines for chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25(11): 311–374 (In Russ.)). https://doi.org/10.15829/1560-4071-2020-408. EDN: LJGGQV.


4. Fan Y., Huang J., Zhou Y. et al. Does the impact of frailty on all-cause mortality in older persons differ between women and men? A meta-analysis. J Am Med Dir Assoc. 2021; 22(3): 606.e1–606.e6. https://doi.org/10.1016/j.jamda.2020.05.059. PMID: 32682600.


5. Турушева А.В., Фролова Е.В., Дегриз Ж.М. Эволюция теории старческой астении. Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2017; 9(1): 117–124. (Turusheva A.V., Frolova E.V., Degryse J.M. Evolution of the frailty concept. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta imeni I.I. Mechnikova = I.I. Mechnikov Bulletin of the North-Western State Medical University. 2017; 9(1): 117–124 (In Russ.)). EDN: YLDZRJ.


6. Ткачева О.Н., Котовская Ю.В., Рунихина Н.К. с соавт. Клинические рекомендации «Старческая астения». Российский журнал гериатрической медицины. 2020; (1): 11–46. (Tkacheva O.N., Kotovskaya Yu.V., Runikhina N.K. et al. Clinical guidelines on frailty. Rossiyskiy zhurnal geriatricheskoy meditsiny = Russian Journal of Geriatric Medicine. 2020; (1): 11–46 (In Russ.)). https://doi.org/10.37586/2686-8636-1-2020-11-46. EDN: JCMOSK.


7. Айрапетов К.В., Голованова Е.Д., Титарева Л.В. Влияние саркопении на гемодинамику у пациентов с сердечно-сосудистой патологией при патологическом старении. Научные результаты биомедицинских исследований. 2023; 9(3): 393–401. (Airapetov K.V., Golovanova E.D., Titareva L.V. The effect of sarcopenia on hemodynamics in patients with cardiovascular pathology in pathological aging. Nauchnyye rezul’taty biomeditsinskikh issledovaniy = Scientific Results of Biomedical Research. 2023; 9(3): 393–401 (In Russ.)). https://doi.org/10.18413/2658-6533-2023-9-3-0-9. EDN: CFUZVK.


8. Мачехина Л.В., Остапенко В.С., Ткачева О.Н. с соавт. Изучение взаимосвязи гормонально-метаболического статуса с синдромом старческой астении среди долгожителей. РМЖ. 2023; (5): 32–38. (Machekhina L.V., Ostapenko V.S., Tkacheva O.N. et al. Study of the hormonal and metabolic condition association with senile asthenia syndrome among long-living persons. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2023; (5): 32–38 (In Russ.)). EDN: UFSAHK.


9. Курмаев Д.П., Булгакова С.В., Удалов Ю.Д. с соавт. Особенности физических и функциональных параметров долгожителей на фоне старческой астении. Современные проблемы здравоохранения и медицинской статистики. 2022; (1): 89–107. (Kurmaev D.P., Bulgakova S.V., Udalov Yu.D. et al. Physical and functional parameters of the centenarians with frailty syndrome. Sovremennyye problemy zdravookhraneniya i meditsinskoy statistiki = Current Problems of Health Care and Medical Statistics. 2022; (1): 89–107 (In Russ.)). https://doi.org/10.24412/2312-2935-2022-1-89-107. EDN: UGEFVL.


10. Бубнова М.Г., Персиянова-Дуброва А.Л. Применение теста с шестиминутной ходьбой в кардиореабилитации. Кардиоваскулярная терапия и профилактика. 2020; 19(4): 102–111. (Bubnova M.G., Persiyanova-Dubrova A.L. Six-minute walk test in cardiac rehabilitation. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2020; 19(4): 102–111 (In Russ.)). https://doi.org/10.15829/1728-8800-2020-2561. EDN: TXSJNX.


11. Габитова М.А., Крупенин П.М., Соколова А.А. с соавт. «Хрупкость» у пациентов старческого возраста с фибрилляцией предсердий как предиктор геморрагических осложнений на фоне лечения прямыми пероральными антикоагулянтами. Сибирский научный медицинский журнал. 2019; 39(6): 70–76. (Gabitova M.A., Krupenin P.M., Sokolova A.A. “Fragility” as a predictor of bleedings in elderly patients with atrial fibrillation taking direct oral anticoagulants. Sibirskiy nauchnyy meditsinskiy zhurnal = Siberian Scientific Medical Journal. 2019; 39(6): 70–76 (In Russ.)). https://doi.org/10.15372/SSMJ20190609. EDN: CBMJEQ.


12. Ortiz A., Sanchez-Nino M.D. Sarcopenia in CKD: A roadmap from basic pathogenetic mechanisms to clinical trials. Clin Kidney J. 2019; 12(1): 110–12. https://doi.org/10.1093/ckj/sfz001. PMID: 30746137. PMCID: PMC6366131.


13. Кобалава Ж.Д., Виллевальде С.В., Боровкова Н.Ю. с соавт. Распространенность маркеров хронической болезни почек у пациентов с артериальной гипертонией: результаты эпидемиологического исследования ХРОНОГРАФ. Кардиология. 2017; 57(10): 39–44. (Kobalava Zh.D., Villevalde S.V., Borovkova N.Yu. et al. Prevalence of markers of chronic kidney disease in patients with arterial hypertension: Results of epidemiological study CHRONOGRAF. Kardiologiya = Cardiology. 2017; 57(10): 39–44 (In Russ.)). https://doi.org/10.18087/cardio.2017.10.10041. EDN: ZIZYGV.


14. Bianchi L., Ferrucci L., Cherubini A. et al. The predictive value of the EWGSOP definition of sarcopenia: Results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2016; 71(2): 259–64. https://doi.org/10.1093/gerona/glv129. PMID: 26333772. PMCID: PMC4723661.


15. Ponikowski P., Voors A.A., Anker S.D. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–200. https://doi.org/10.1093/eurheartj/ehw12. PMID: 27207191.


16. Драпкина О.М., Шепель Р.Н. Хроническая сердечная недостаточность и «парадокс ожирения». Журнал Сердечная недостаточность. 2016; 17(6): 398–404. (Drapkina O.M., Shepel R.N. Chronic heart failure and the “obesity paradox”. Zhurnal Serdechnaya nedostatochnost’ = Heart Failure Journal. 2016; 17(6): 398–404 (In Russ.)). https://doi.org/10.18087/rhfj.2016.6.2263. EDN: XIMJCZ.


17. Киселева Г.В., Рафальская К.А. Распространенность гериатрических синдромов у пациентов врача общей практики. Российский семейный врач. 2017; 21(4): 21–28. (Kiseleva G.V., Rafalskaya K.A. The prevalence of geriatric syndromes in general practice. Rossiyskiy semeynyy vrach = Russian Family Doctor. 2017; 21(4): 21–28 (In Russ.)). https://doi.org/10.17816/RFD2017421-28. EDN: NGOEHY.


18. Muller M., Smulders Y.M., de Leeuw P.W., Stehouwer C.D. Treatment of hypertension in the oldest old: A critical role for frailty? Hypertension. 2014; 63(3): 433–41. https://doi.org/10.1161/HYPERTENSIONAHA.113.00911. PMID: 24324042.


19. Benetos A., Rossignol P., Cherubini A. et al. Polypharmacy in the aging patient: Management of hypertension in octogenarians. JAMA. 2015; 314(2): 170–80. https://doi.org/10.1001/jama.2015.7517. PMID: 26172896.


20. Остроумова О.Д., Черняева М.С., Морозов А.П. Целевые уровни артериального давления у пациентов с артериальной гипертензией и синдромом старческой астении. Системные гипертензии. 2019; 16(4): 52–60. (Ostroumova O.D., Cherniaeva M.S., Morozov A.P. Target blood pressure levels in patients with arterial hypertension and frailty. Sistemnye gipertenzii = Systemic Hypertension. 2019; 16(4): 52–60 (In Russ.)). https://doi.org/10.26442/2075082X.2019.4.190577. EDN: VVZKHL.


21. Александрова Е.Б. Хроническая сердечная недостаточность у больных гипертонической болезнью и ишемической болезнью сердца: возрастные и гендерные аспекты. Кардиология. 2013; 53(7): 40–44. (Alexandrova E.B. Chronic heart failure in patients with arterial hypertension and ischemic heart desease: Age and gender characteristics. Kardiologiya = Cardiology. 2013; 53(7): 40–44 (In Russ.)). EDN: RGRNSD.


22. Зуева И.Б., Ванаева К.И., Санец Е.Л. с соавт. Взаимосвязь факторов сердечно-сосудистого риска с когнитивными функциями у пациентов среднего возраста. Артериальная гипертензия. 2011; 17(5): 432–440. (Zueva I.B., Vanaeva K.I., Sanez E.L. et al. Association of cognitive function with cardiovascular risk factors in middle age individuals. Arterial’naya gipertenziya = Arterial Hypertension. 2011; 17(5): 432–440 (In Russ.)). https://doi.org/10.18705/1607-419X-2011-17-5-432-440. EDN: RRUOAV.


23. Starr J.M., Whalley L.J., Inch S., Shering P.A. Blood pressure and cognitive function in healthy old people. J Am Geriatr Soc. 1993; 41(7): 753–56. https://doi.org/10.1111/j.1532-5415.1993.tb07466.x. PMID: 8315187.


24. Оганов Р.Г., Симаненков В.И., Бакулин И.Г. с соавт. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019; 18(1): 5–66. (Oganov R.G., Simanenkov V.I., Bakulin I.G. et al. Comorbidities in clinical practice. algorithms for diagnostics and treatment. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2019; 18(1): 5–66 (In Russ.)). https://doi.org/10.15829/1728-8800-2019-1-5-66. EDN: YXKKAP.


25. Боголепова А.Н, Васенина Е.Е., Гомзякова Н.А. с соавт. Клинические рекомендации «Когнитивные нарушения у пациентов пожилого и старческого возраста». Журнал неврологии и психиатрии им. С.С. Корсакова. 2021; 121(10–3): 6–137. (Bogolepova A.N., Vasenina E.E., Gomzyakova N.A. et al. Clinical guidelines for cognitive disorders in elderly and older patients. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2021; 121(10–3): 6–137 (In Russ.)). https://doi.org/10.17116/jnevro20211211036. EDN: MPUDYF.


About the Autors


Victoria A. Safronenko, MD, PhD (Medicine), associate professor of the Department of internal medicine No. 1, Rostov State Medical University of the Ministry of Healthcare of Russia. Address: 344022, Rostov-on-Don, 29 Nakhichevansky Lane.
E-mail: v.chugunova@mail.ru
ORCID: https://orcid.org/0000-0002-6965-5019
Anna I. Chesnikova, MD, Dr. Sci. (Medicine), professor, head of the Department of internal medicine No. 1, Rostov State Medical University of the Ministry of Healthcare of Russia. Address: 344022, Rostov-on-Don, 29 Nakhichevansky Lane.
E-mail: rostov-ossn@yandex.ru
ORCID: https://orcid.org/0000-0002-9323-592X


Similar Articles


Бионика Медиа